Loyal portfolio

Cytovia logo

Cytovia

Health · USA

PilotUSAINSEADSDG 3
Daniel TeperA

Daniel Teper · Anna Baran

About Cytovia

Cytovia Therapeutics is a new biotech company formed in 2019 to build a portfolio of products to harness the power of Natural Killer (NK) Cells in the treatment of cancer and viral infections. Our core technologies are gene edited CAR NK cells produced from stem cells (iPSCs) and NK engager multi-specific antibodies.

Visit website

Founders

  • Daniel Teper

    Daniel Teper

  • A

    Anna Baran

Details

Stage
Pilot
Sector
Health
Country
USA
Region
USA
Source
INSEAD
UN SDGs
SDG 3